Back to search

Article

Shenling Baizhu San Ameliorates Metabolic-Associated Fatty Liver Disease Complicated with Sarcopenia via Regulating AMPKα Signaling

2026-05-06

Abstract excerpt

<title>Abstract</title> <p> <bold>Background and purpose:</bold> Metabolic-associated fatty liver disease (MAFLD) complicated with sarcopenia (SP) is associated with increased mortality and represents a significant threat to human health. Shenling Baizhu San (SLBZS) has demonstrated therapeutic efficacy in both MAFLD and SP. However, the mechanisms underlying the effects of SLBZS in MAFLD complicated with SP re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8e75bd83-f800-5697-b56d-9a2ee758f900
DOI
10.21203/rs.3.rs-9439368/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Shenling Baizhu San Ameliorates Metabolic-Associated Fatty Liver Disease Complicated with Sarcopenia via Regulating AMPKα SignalingDOI 10.21203/rs.3.rs-9439368/v1
Exercise ameliorates sarcopenia and metabolic dysfunction–associated steatohepatitis through activation of skeletal muscle PGC-1α/SIRT1 signaling in miceSemantic proximity
Exercise protects against AMLN diet-induced lipid deposition in hepatocytes during MAFLD progression by regulating the UPRmt and FGF21 secretionSemantic proximity
Metformin's Effect on Non-Alcoholic Fatty Liver Disease through the miR-200a-5p and AMPK/SERCA2b PathwaySemantic proximity
The Effect of Cardiometabolic Drugs on Non-Alcoholic Fatty Liver Disease (NAFLD), Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Semantic proximity
Mammalian Ste20-Like Kinase 1 Regulates AMPK to Mitigate the Progression of Non-Alcoholic Fatty Liver DiseaseSemantic proximity
<i>Patolakaturohiniyadi Kashayam</i> , exerts anti-steatotic and anti-obesogenic effects via coordinated regulation of lipid metabolism, inflammation, and incretin signallingSemantic proximity
Hepatic HIF2α modulates extra-hepatic disease-associated phenotypes during metabolic dysfunction-associated steatotic liver diseaseSemantic proximity
Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.Semantic proximity
A new dietary rat model fully recapitulates metabolic dysfunction-associated steatotic liver disease pathophysiology and mimics human disease with advanced liver fibrosis and portal hypertensionSemantic proximity
Combined Metabolic Activators decrease liver steatosis by activating mitochondrial metabolism in a Golden Syrian hamster studySemantic proximity
WITHDRAWN: Endurance Training Alleviates Metabolic-associated Fatty-liver Disease (MAFLD)-related Testicular Impairments via ER Stress RegulationSemantic proximity
Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in chronic liver disease rats and humansSemantic proximity
Select a neighboring publication to make it the new centre.